{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:44:27Z","timestamp":1791308667729,"version":"4.3.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hans H. Hirsch"},{"name":"Norwegian Extra Foundation for Health and Rehabilitation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.antiviral.2011.07.012","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T19:39:25Z","timestamp":1311536365000},"page":"115-123","source":"Crossref","is-referenced-by-count":82,"title":["Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells"],"prefix":"10.1016","volume":"92","author":[{"given":"Biswa Nath","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bernhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore Jarl","family":"Gutteberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Hanssen","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.07.012_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350701200104","article-title":"Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones","volume":"12","author":"Ali","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2011.07.012_b0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0924-8579(94)90015-9","article-title":"Fleroxacin: the newly introduced once-daily quinoline","volume":"4(2)","author":"Andriole","year":"1994","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2011.07.012_b0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00204-009-0509-9","article-title":"A comparative analysis of chromosomal aberrations in cultured human lymphocytes due to fluoroquinolone drugs at different expression periods","volume":"84","author":"Anupama","year":"2010","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.antiviral.2011.07.012_b0020","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1600-6143.2008.02269.x","article-title":"Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression","volume":"8","author":"Bernhoff","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2011.07.012_b0025","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1128\/JVI.01737-09","article-title":"Leflunomide inhibition of BK virus replication in renal tubular epithelial cells","volume":"84","author":"Bernhoff","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.07.012_b0030","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.bjp.0701302","article-title":"Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells","volume":"121","author":"Cavet","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2011.07.012_b0035","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/AAC.41.12.2693","article-title":"Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells","volume":"41","author":"Cavet","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.07.012_b0040","series-title":"Fields Virology","first-page":"1997","article-title":"Polyomavirinae: the viruses and their replication","author":"Cole","year":"1996"},{"key":"10.1016\/j.antiviral.2011.07.012_b0045","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jmb.2010.02.042","article-title":"Conformational rearrangements of SV40 large T antigen during early replication events","volume":"397","author":"Cuesta","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2011.07.012_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bmt.1705886","article-title":"Polyomavirus BK infection in blood and marrow transplant recipients","volume":"41","author":"Dropulic","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2011.07.012_b0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.07.012_b0060","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/0006-2952(88)90495-9","article-title":"Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid","volume":"37","author":"Ferrazzi","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2011.07.012_b0065","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1600-6143.2008.02402.x","article-title":"Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants","volume":"8","author":"Funk","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2011.07.012_b0070","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2215\/CJN.08261109","article-title":"Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation","volume":"5","author":"Gabardi","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.antiviral.2011.07.012_b0075","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20072097","article-title":"Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology","volume":"205","author":"Gosert","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2011.07.012_b0185","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1128\/AAC.00046-11","article-title":"CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human progenitor derived astrocytes","volume":"55","author":"Gosert","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.07.012_b0080","series-title":"DNA Replication in Eukaryotic Cells","article-title":"SV40 and polyomavirus DNA replication","author":"Hassell","year":"1996"},{"key":"10.1016\/j.antiviral.2011.07.012_b0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0022-1759(94)90294-1","article-title":"A two fusion partner system for raising antibodies against small immunogens expressed in bacteria","volume":"173","author":"Hey","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2011.07.012_b0090","series-title":"Transplant Infections","first-page":"465","article-title":"Polyoma and papilloma virus infections after hematopoietic stem cell or solid organ transplantation","author":"Hirsch","year":"2010"},{"key":"10.1016\/j.antiviral.2011.07.012_b0095","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/324425","article-title":"Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy","volume":"184","author":"Hirsch","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.07.012_b0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus BK","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.07.012_b0105","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/AAC.37.10.2193","article-title":"Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers","volume":"37","author":"Israel","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.07.012_b0110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2011.07.012_b0115","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1128\/AAC.38.12.2702","article-title":"Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model","volume":"38","author":"Kang","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.07.012_b0120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1006\/viro.1993.1517","article-title":"Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin","volume":"196","author":"Kerr","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.07.012_b0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1399-3062.2008.00334.x","article-title":"Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication","volume":"10","author":"Koukoulaki","year":"2008","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.07.012_b0130","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/427291","article-title":"Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Leung","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.07.012_b0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/11536360-000000000-00000","article-title":"Safety profile of the fluoroquinolones: focus on levofloxacin","volume":"33","author":"Liu","year":"2010","journal-title":"Drug Saf."},{"key":"10.1016\/j.antiviral.2011.07.012_b0140","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1128\/AAC.45.12.3524-3530.2001","article-title":"Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers","volume":"45","author":"Naber","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.07.012_b0145","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/jmv.21605","article-title":"Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients","volume":"81","author":"Olsen","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2011.07.012_b0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0166-3542(88)90004-6","article-title":"Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase","volume":"9","author":"Portolani","year":"1988","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.07.012_b0155","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/497080","article-title":"Anti-BK virus activity of ciprofloxacin and related antibiotics","volume":"41","author":"Randhawa","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.07.012_b0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00007890-200208270-00009","article-title":"Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy","volume":"74","author":"Randhawa","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2011.07.012_b0165","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00974-10","article-title":"1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells","volume":"54","author":"Rinaldo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.07.012_b0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1586\/14787210.5.1.105","article-title":"Antivirals for the treatment of polyomavirus BK replication","volume":"5","author":"Rinaldo","year":"2007","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2011.07.012_b0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1399-3062.2006.00166.x","article-title":"Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients","volume":"8","author":"Trofe","year":"2006","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.07.012_b0180","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1128\/AAC.33.10.1655","article-title":"Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis","volume":"33","author":"Wolfson","year":"1989","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211003834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211003834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T08:38:40Z","timestamp":1686213520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211003834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0166354211003834"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.07.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}